Diagnostic and Prognostic Power of Active DNA Demethylation Pathway Intermediates in Acute Myelogenous Leukemia and Myelodysplastic Syndromes

Diagnostic and Prognostic Power of Active DNA Demethylation Pathway Intermediates in Acute Myelogenous Leukemia and Myelodysplastic Syndromes

Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) are characterized by genomic instability, which may arise from the global hypomethylation of the DNA. The active DNA demethylation process may be linked with aberrant methylation and can be involved in leukemogenesis. The levels of 5-m...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Aleksandra Skalska-Bugala, Marta Starczak, Łukasz Szukalski, Maciej Gawronski, Agnieszka Siomek-Gorecka, Justyna Szpotan, Anna Labejszo, Ewelina Zarakowska, Anna Szpila, Anna Jachalska, Adriana Szukalska, Marcin Kruszewski, Anna Sadowska, Aleksandra Wasilow, Patrycja Baginska, Jaroslaw Czyz, Ryszard Olinski, Rafal Rozalski, Daniel Gackowski
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: MDPI AG 2022-03-01
Sarja:Cells
Aiheet:
acute myelogenous leukemia
myelodysplastic syndromes
biomarkers
active demethylation
5-hydroxymethylcytosine
5-carboxycytosine
Linkit:https://www.mdpi.com/2073-4409/11/5/888

Internet

https://www.mdpi.com/2073-4409/11/5/888

Samankaltaisia teoksia